TP53 and cancer: To evaluate how m6A-modified DEGs affect the progression of ccRCC patients, functional enrichment analysis was performed, showing that these genes were enriched in cell division, DNA replication, cell cycle, PI3K-AKT, and p53 pathways, which were related to cancer (Figure 1d-e).